Document is current
Any future updates will be listed below
-
Authors
Gorelik, Andrii https://orcid.org/0000-0001-5354-4042
Đukić, Nina https://orcid.org/0009-0004-6120-6421
Smith, Rebecca https://orcid.org/0000-0002-1658-5635
Chatrin, Chatrin https://orcid.org/0000-0002-5666-3175
Suyari, Osamu https://orcid.org/0009-0008-3258-8722
Matthews, Jason
Ahel, Ivan https://orcid.org/0000-0002-9446-3756
-
Funding
Funding for this research was provided by:
Wellcome Trust (224095/Z/21/Z)
Wellcome Trust (210634,223107,302632)
UKRI | Biotechnology and Biological Sciences Research Council (BB/R007195/1,BB/W016613/1)
Cancer Research UK (C35050/A22284)
- License Information
-
More Information
Article History
Received: 22 June 2025
Revised: 30 October 2025
Accepted: 18 November 2025
First Online: 1 December 2025
Disclosure and competing interests statement
: JM is a consultant for Duke Street Bio Inc. and NOA Therapeutics Inc. The remaining authors declare no competing interests.
